Showing results (1-10 of 263) with videos related to
Sort By:
Pageof 27
Aktuelle Urologie|March 29, 2007
[Nephron-sparing therapy for renal tumors]B Brehmer, A H Mahnke, G JakseProstate Cancer and Prostatic Diseases|September 13, 2003
Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissueB Brehmer, S Biesterfeld, G JakseAktuelle Urologie|October 2, 2007
[Solitary peritoneal carcinomatosis in prostate cancer]B Brehmer, A Makris, A Wellmann, et al.Urologia Internationalis|October 13, 2001
Radical prostatectomy in patients with previous groin hernia repair using synthetic nonabsorbable meshH Borchers, B Brehmer, H van Poppel, et al.Urological Research|October 6, 1998
Induction of drug-resistant bladder carcinoma cells in vitro: impact on polychemotherapy with cisplatin, methotrexate and vinblastine (CMV)D Rohde, B Brehmer, T Kapp, et al.British Journal of Urology|April 2, 1998
Transforming growth factor-beta1 serum concentration in patients with prostatic cancer and benign prostatic hyperplasiaJ M Wolff, T Fandel, H Borchers, et al.Der Urologe. Ausg. A|May 8, 1999
[Radical perineal prostatectomy without lymphadenectomy. Patients with cT1 + 2, G1 +2, PSA < or = 10 ng/ml prostate carcinoma]G Jakse, B Brehmer, J M Wolff, et al.European Urology|August 31, 2001
Perioperative morbidity of the extended radical perineal prostatectomyB Brehmer, H Borchers, R Kirschner-Hermanns, et al.Der Urologe. Ausg. A|April 3, 2003
[Potency-sparing radical perineal prostatectomy]G Jakse, B Brehmer, H Borchers, et al.Urologia Internationalis|June 30, 1998
Cytokeratin 8/18 levels in patients with prostate cancer and benign prostatic hyperplasiaJ M Wolff, H Borchers, B Brehmer, et al.Pageof 27